The deal priced below last closing price of $6.31. Maxim is acting as sole book running manager for the offering.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on APRE:
- Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common Stock
- Aprea Therapeutics proposes public offering of common stock, amount not stated
- Aprea Therapeutics announces Phase II SBIR award from NCI
- Aprea Therapeutics announces one-for-twenty reverse stock split
- Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split